8
Participants
Start Date
October 16, 2024
Primary Completion Date
March 19, 2025
Study Completion Date
June 19, 2025
BI 765883
BI 765883
gemcitabine
gemcitabine
nab-paclitaxel
nab-paclitaxel
Cliniques Universitaires Saint-Luc, Brussels
UZ Leuven, Leuven
Universitätsklinikum Hamburg, Eppendorf, Hamburg
Hospital Universitario Ramon Y Cajal, Madrid
Florida Cancer Specialists-Sarasota-61670, Sarasota
CTR Eugène Marquis, Rennes
SCRI Oncology Partners, Nashville
Universitätsklinikum Heidelberg, Heidelberg
CTR Leon Berard, Lyon
The University of Texas MD Anderson Cancer Center, Houston
HealthONE, Denver
Klinikum der Universität München AÖR, München
INS Gustave Roussy, Villejuif
Yale Cancer Center, New Haven
National Cancer Center Hospital East, Chiba, Kashiwa
National Cancer Center Hospital, Tokyo, Chuo-ku
Hospital Clínic de Barcelona, Barcelona
Lead Sponsor
Boehringer Ingelheim
INDUSTRY